ABATIXENT

Brand name authorized in: Lithuania Poland

Active ingredients

The drug ABATIXENT contains one active pharmaceutical ingredient (API):

1 Apixaban
UNII 3Z9Y7UWC1J - APIXABAN

Apixaban is a potent, oral, reversible, direct and highly selective active site inhibitor of factor Xa. It does not require antithrombin III for antithrombotic activity. Apixaban inhibits free and clot-bound factor Xa, and prothrombinase activity. By inhibiting factor Xa, apixaban prevents thrombin generation and thrombus development.

Read about Apixaban

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Apixaban
B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AF Direct factor Xa inhibitors
Discover more medicines within B01AF02

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1093513, 1093514, 1093515, 1093516, 1093517, 1093518, 1093519, 1093520, 1093521, 1093522, 1093523, 1093524, 1093525, 1093526, 1093527, 1093528, 1093529, 1093530, 1093531, 1093532, 1093533, 1093534, 1093535, 1093536, 1093537, 1093538, 1093539, 1093540, 1093541, 1093542, 1093543, 1093544
PL
Rejestru Produktów Leczniczych
Identifier(s): 100428090, 100428108